Phospholipids released from activated platelets improve platelet aggregation and endothelial cell migration

Platelets

Volumn 12, Issue 3, 2001, Pages 163-170

  Xiao, H ^a   Siddiqui, R A ^a   Al Hassani, M H ^a   Sliva, D ^a   Kovacs, R J ^a  

^a METHODIST RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; BUTANOL; CALCIMYCIN; PHOSPHATIDIC ACID; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLSERINE; PHOSPHOLIPID; SPHINGOSINE 1 PHOSPHATE; THROMBIN;

ANGIOGENESIS; ARTICLE; CELL MIGRATION; CHEMOTAXIS; CONTROLLED STUDY; ENDOTHELIUM CELL; FREEZING; HEMOSTASIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SUPERNATANT; THAWING; THIN LAYER CHROMATOGRAPHY; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

ANIMALS; BLOOD PLATELETS; CATTLE; CELL MOVEMENT; CHEMOTAXIS; CHROMATOGRAPHY, THIN LAYER; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ENDOTHELIUM, VASCULAR; HUMANS; KINETICS; PHOSPHOLIPIDS; PLATELET ACTIVATION; PLATELET AGGREGATION; THROMBIN;

BOVINAE;

EID: 0035052260     PISSN: 09537104     EISSN: None     Source Type: Journal    
DOI: 10.1080/09537100120039389     Document Type: Article

References (41)

1. Phosphatidic acid elicits calcium mobilization and actin polymerization through a tyrosine kinase-dependent process in human neutrophils: A mechanism for induction of chemotaxis
2. Identification of molecular species of lysophosphatidic acid produced when platelets are stimulated by thrombin
3. Decanoyl lysophosphatidic acid induces platelet aggregation through an extracellular action. Evidence against a second messenger role for lysophosphatidic acid
4. Sphingosine-1-phosphate is a blood constituent released from activated platelets, possibly playing a variety of physiological and pathophysiological roles
5. Quantitative measurement of sphingosine 1-phosphate in biological samples by acylation with radioactive acetic anhydride
6. Sphingosine-1-phosphate: A platelet-activating sphingolipid released from agonist-stimulated human platelets
7. Induction of endothelial cell chemotaxis by sphingosine 1-phosphate and stabilization of endothelial monolayer barrier function by lysophosphatidic acid, potencial mediators of hematopoietic angiogenesis
8. Involvement of focal adhesion kinase in inhibition of motility of human breast cancer cells by sphingosine 1-phosphate
9. Loss of membrane phospholipid asymmetry in platelets and red cells may be associated with calcium-induced shedding of plasma membrane and inhibition of aminophospholipid translocase
10. Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: An isolated defect in platelet procoagulant activity
11. Role of calcium and calpain in complement-induced vesiculation of the platelet plasma membrane and in the exposure of the platelet factor Va receptor
12. Platelet procoagulant activity and microvesicle formation. Its putative role in hemostasis and thrombosis
13. Transcellular activation of platelets and endothelial cells by bioactivate lipids in platelet microparticles
14. 2+ mobilization, barrier dysfunction, prostaglandin synthesis, and platelet derived growth factor mRNA expression cultured endothelium
15. Platelet activation by thrombin can be directly measured in whole blood through the use of the peptide GPRP and flow cytometry: Methods and clinical applications
16. Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1
17. Phospholipid base exchange activity in rat liver plasma membranes
18. Characterization and purification of neutrophil ecto-phosphatidic acid phosphohydrolase
19. Phospholipid metabolism in stimulated human platelets. Changes in phosphatidylinositol, phosphatidic acid, and lysophospholipids
20. Positive regulation of mu-calpain action by polyphopsphoinosides
21. Messenger functions of phosphotidic acid
22. Ceremide. A novel second messenger
23. The novel second messenger ceramide: Identification, mechanism of action, and cellular activity
24. Differential effects of propranolol on responses to receptor-dependent and receptor-independent stimuli in human neutrophils
25. A novel ectophosphatidic acid phosphohydrolase activity mediates activation of neutrophil superoxide generation by exogenous phosphatidic acid
26. Stimulation of phosphatidic acid production in platelets precedes the formation of arachidonate and parallels the release of serotonin
27. Lysophosphatidate-induced cell proliferation: Identification and dissection of signaling pathways mediated by G proteins
28. Lysophosphatidic acid induces neuronal shape changes via a novel, receptor-mediate signaling pathway: Similarity to thrombin action
29. The bioactive phospholipid lysophosphatidic acid is released from activated platelets
30. Pathological changes in cerebral arteries following experimental subarachnoid hemorrhage: Role of blood platelets
31. Conversion from chronic coronary heart disease syndromes. Role of platelets and platelet products
32. Angiogenesis in cancer, vascular, rheumatoid and other diseases
33. Mechanisms of angiogenesis
34. Inhibition of tumor angiogenesis using a soluble receptor established a role for Tie 2 in pathologic vascular growth
35. Glioblastoma growth inhibited in vivo by a dominant-negative FLK-1 mutant
36. Diglyceride lipase: A pathway for arachidonate release from human platelets
37. Inceased plasma adrenaline concentrations in benign essential hypertension
38. Plasma catecholamines in stress and exercise
39. Differentiated sympathetic activation during mental stress evoked by the stroop test
40. Abnormal platelet reactivity in men with premature coronary heart disease
41. Myocardial ischemia and ventricular arrhythmias precipitated by physiological concentrations of adrenaline in patients with coronary heart disease